OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation.
about
Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosisPotential Gene Interactions in the Cell Cycles of Gametes, Zygotes, Embryonic Stem Cells and the Development of CancerPotential Role of Induced Pluripotent Stem Cells (IPSCs) for Cell-Based Therapy of the Ocular SurfaceDICER-dependent biogenesis of let-7 miRNAs affects human cell response to DNA damage via targeting p21/p27.Pathway Regulation of p63, a Director of Epithelial Cell FateMicroRNA-20a-5p contributes to hepatic glycogen synthesis through targeting p63 to regulate p53 and PTEN expression.Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death.Network-based identification of microRNAs as potential pharmacogenomic biomarkers for anticancer drugs.PRMT5 enhances generation of induced pluripotent stem cells from dairy goat embryonic fibroblasts via down-regulation of p53.Cell cycle and pluripotency: Convergence on octamer‑binding transcription factor 4 (Review).Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cellsAlternative mechanisms of miR-34a regulation in cancer.The delta opioid peptide D-Alanine 2, Leucine 5 Enkephaline (DADLE)-induces neuroprotection through cross-talk between the UPR and pro-survival MAPK-NGF-Bcl2 signalling pathways via modulation of several micro-RNAs in SH-SY5Y cells subjected to ER sHighly expressed histone deacetylase 5 promotes the growth of hepatocellular carcinoma cells by inhibiting the TAp63-maspin pathway.Cardamonin reduces chemotherapy resistance of colon cancer cells via the TSP50/NF-κB pathway in vitro.OCT4B regulates p53 and p16 pathway genes to prevent apoptosis of breast cancer cells.The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo
P2860
Q26774960-449CC380-4098-4D5E-8AC8-ADB095EFFB70Q26781101-6C815FCD-3A8B-4639-A608-4A71B31B9413Q26799621-3C755BF1-9508-447A-862A-296D50E82DD1Q35088959-6F2F801B-E209-44AF-8687-E919EF6CDF5BQ35545782-666921A0-C620-49DC-A421-83AB3424D50FQ37117127-1EE7225F-51F8-465C-858A-49773193330DQ37167523-11E95D0A-4C95-431A-AF14-EF14C37A69AFQ37564492-0B0978C5-B814-442D-B0D0-FA57D63BA35FQ39094220-BD2047B0-B0A9-48C0-8483-262870FB2378Q40049641-2A57879F-BF72-437A-A333-1530EB6A8288Q41841045-21532E8F-ECB8-484A-9423-C46196906E35Q47117322-CB62B0A4-FA34-4BAB-A35B-AD2D9EFB1A23Q47261323-D602597F-62B7-43F9-BD5A-FFA8663E9B7CQ52595049-E1BA0672-B822-48D4-AF53-3409CFA8FF02Q55316813-52775677-944E-4454-BBE6-4E4DBEB5690FQ55365177-6F5EC729-E96B-4209-9119-2D605840BD4AQ58718462-D34A1FC4-4776-4B6D-9B44-6A99734D000F
P2860
OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
OCT4 as a target of miR-34a st ...... ote human cell transformation.
@ast
OCT4 as a target of miR-34a st ...... ote human cell transformation.
@en
type
label
OCT4 as a target of miR-34a st ...... ote human cell transformation.
@ast
OCT4 as a target of miR-34a st ...... ote human cell transformation.
@en
prefLabel
OCT4 as a target of miR-34a st ...... ote human cell transformation.
@ast
OCT4 as a target of miR-34a st ...... ote human cell transformation.
@en
P2093
P2860
P356
P1476
OCT4 as a target of miR-34a st ...... ote human cell transformation.
@en
P2093
A R M R Amin
F A Cucinotta
P2860
P356
10.1038/CDDIS.2013.563
P577
2014-01-23T00:00:00Z